NEWSBRIEF: A nonprofit group called Public Citizen is asking the FDA to immediately yank the fibromyalgia drug Savella (milnacipran) off the market. ...
Sales of Savella, Forest's new drug for fibromyalgia, totaled $15.4 million, ahead of forecasts for $12.7 million. Launched in April, Savella is one of the ...
Fibromyalgia Support Group, 10 am Schliemann Center for Women's Health Education, Baxter Regional Medical Center. 508-2345. Growing Through Grief, 1-3 pm ...
A class of drugs called SSRIs (Selective Serotonin Reuptake Inhibitors) has been shown to give relief to patients suffering from chronic constipation. ...
Sales of Lyrica, a pain and fibromyalgia drug, climbed 17% to $820 million; cancer drug Sutent, up 33% to $293 million; Viagra, up 9% to $549 million; ...
25) A hypothetical fibromyalgia drug that improved sleeping quality better than the top-selling drugs on the market would capture a large portion of the ...
Cymbalta is a $3.2 billion-a-year treatment for depression, anxiety and fibromyalgia. Lilly's fourth-quarter earnings per share missed Wall Street estimates ...
Its initial approval in this country is solely as a treatment for fibromyalgia syndrome (FMS). It becomes the third drug to be approved for this disorder: ...
Email this story
